2015
DOI: 10.1007/s00404-015-3711-4
|View full text |Cite
|
Sign up to set email alerts
|

Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: a randomised controlled pilot study

Abstract: Consumption of L. acidophilus La-14, L. rhamnosus HN001 in combination with bovine lactoferrin leads to vaginal detection; even 1 week after consumption was stopped. This provides a basis for future studies on urogenital tract health.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
61
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(69 citation statements)
references
References 15 publications
6
61
0
1
Order By: Relevance
“…In addition, when L1 and L2 were orally administered as a mixture (PM), both L1 and L2 were detected in the vagina, as previously reported [18]. Administration of L1, L2, or PM reduced the number of GV detected in the vagina.…”
Section: Discussionsupporting
confidence: 77%
See 3 more Smart Citations
“…In addition, when L1 and L2 were orally administered as a mixture (PM), both L1 and L2 were detected in the vagina, as previously reported [18]. Administration of L1, L2, or PM reduced the number of GV detected in the vagina.…”
Section: Discussionsupporting
confidence: 77%
“…Oral administration of the probiotic mixture (PM; containing L1 and L2) resulted in the colonization of L1 and L2 in the vaginas of healthy women [18]. To determine whether these probiotics could also colonize the vaginas of mice, we orally or intravaginally administered PM or one of its probiotic components, L1 or L2, and assessed the vaginas from the presence of attached probiotics by qPCR (Figure 1).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…There is growing evidence that oral probiotics not only influence the GI tract directly, but also have immunomodulatory effects at distant sites, including the urogenital and respiratory tracts, oral cavity/dentition, mammary gland and skin. Although oral probiotics can prevent and/or decrease frequency or severity of diseases outside of the gastrointestinal tract (i.e., an indirect effect) (Alberda et al, 2007; Lappin et al, 2009; Di Nardo et al, 2014; Esposito et al, 2014; Lee et al, 2015; Zuccotti et al, 2015; Fuchs-Tarlovsky et al, 2016; Gruner et al, 2016; Vieira et al, 2016; Zamani et al, 2016), few studies have directly evaluated the appearance of orally administered probiotic species or changes in host microbial communities at distant sites (De Alberti et al, 2015; Mastromarino et al, 2015; Treven et al, 2015). A recent study in pre-menopausal women demonstrated an increase in orally administered probiotic species in vaginal swabs using qPCR analysis, setting the stage for use of oral probiotics to prevent or treat urogenital infections (Mezzasalma et al, 2017).…”
Section: Discussionmentioning
confidence: 99%